Masafumi Kurosumi
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 147 publications
Association of Programmed Death-Ligand 1 Expression in Relation to Tumor-Infiltrating Lymphocyte Concentration and Histological Type with Outcomes of Triple-Negative Breast Cancer.
Journal: Journal of Nippon Medical School = Nippon Ika Daigaku zasshi
Published: September 03, 2025
Comparison of proportions and prognostic impact of pathological complete response between evaluations of representative specimen and total specimen in primary breast cancer after neoadjuvant chemoradiotherapy: an ancillary study of JCOG0306.
Journal: Breast cancer research and treatment
Published: April 06, 2024
Significance of MUC1 and β-Catenin Localization in Mucinous Carcinoma of the Breast.
Journal: Anticancer research
Published: March 02, 2024
Comparison of locoregional recurrence risk among nipple-sparing mastectomy, skin-sparing mastectomy, and simple mastectomy in patients with ductal carcinoma in situ: a single-center study.
Journal: Breast cancer (Tokyo, Japan)
Published: January 30, 2024
Correction to: Validation of a nuclear grading system for resected stage I-IIIA, high-risk, node-negative invasive breast carcinoma in the N·SAS-BC 01 trial.
Journal: Breast cancer (Tokyo, Japan)
Published: May 02, 2022
Validation of a nuclear grading system for resected stage I-IIIA, high-risk, node-negative invasive breast carcinoma in the N·SAS-BC 01 trial.
Journal: Breast cancer (Tokyo, Japan)
Published: November 30, 2021
One DNA Methylation Regulates CHIP Gene Expression of Human Breast Cancer and Predicts Recurrence.
Journal: Anticancer research
Published: November 25, 2021
Optimal Treatment Duration of Neoadjuvant Endocrine Therapy for Women Aged 60 Years or Older with Estrogen Receptor-Positive, HER2-Negative Invasive Breast Cancer.
Journal: Journal of Nippon Medical School = Nippon Ika Daigaku zasshi
Published: November 30, 2020
Relationships between pathological factors and long-term outcomes in patients enrolled in two prospective randomized controlled trials comparing the efficacy of oral tegafur-uracil with CMF (N·SAS-BC 01 trial and CUBC trial).
Journal: Breast cancer research and treatment
Published: September 02, 2020
Nuclear grade and comedo necrosis of ductal carcinoma in situ as histopathological eligible criteria for the Japan Clinical Oncology Group 1505 trial: an interobserver agreement study.
Journal: Japanese journal of clinical oncology
Published: August 11, 2020
Correction to: Histological classification of breast tumors in the General Rules for Clinical and Pathological Recording of Breast Cancer (18th edition).
Journal: Breast cancer (Tokyo, Japan)
Published: May 21, 2020
Last Updated: 09/26/2026